NEUROBELL NOMINEES LIMITED

NeuroBell Nominees Limited is an innovative medical‑technology company dedicated to improving outcomes for the most vulnerable patients – newborns in intensive care. Recognising that seizures are the commonest sign of neonatal brain injury yet often go unnoticed without specialised monitoring, NeuroBell has created a portable EEG system that can be placed at the bedside of infants in the NICU. The device not only records brain activity but also incorporates automated seizure‑detection algorithms, delivering rapid, reliable alerts that enable clinicians to intervene promptly.

The company’s flagship solution bridges a critical gap in neonatal care, offering a user‑friendly, bedside‑ready platform that brings specialist neurological monitoring to units that may lack on‑site expertise. By streamlining diagnosis and treatment, NeuroBell’s technology aims to reduce the long delays that currently jeopardise the health of infants—particularly the one in 200 births who suffer brain injury. Backed by a network of partners and funders, NeuroBell serves hospitals, neonatologists and intensive‑care teams committed to safeguarding newborn brain health.